Neuregulin 1 genotype and schizophrenia.
The neuregulin 1 (NRG1) gene has been the subject of considerable excitement within the psychiatric genetics literature since it was originally identified as a potential susceptibility locus for schizophrenia. Here we provide an update of our first meta-analysis of this association. Case-control and family-based genetic association studies of the NRG1 gene in healthy control groups and clinically diagnosed schizophrenia patients were included. We repeated the search strategy in our earlier meta-analysis for studies published between December 31, 2005, and September 30, 2007, and updated the results of our original meta-analysis accordingly. Superficially, the results of our updated meta-analysis are consistent with those in our previous report, although it is notable that the strength of evidence as based on our haplotype analysis has weakened over this period. The evidence for association of the SNP8NRG221533 polymorphism continued to be nonsignificant. We discuss a number of problems in the interpretation of a disparate and inconsistent gene-disease association literature, including the difficulties associated with determining what constitutes replication across studies which vary in their methods, marker sets employed, phenotype definition, and other study characteristics.
Munafò
Marcus R
MR
Department of Experimental Psychology, University of Bristol, Bristol BS8 1TU, UK. marcus.munafo@bristol.ac.uk
Attwood
Angela S
AS
Flint
Jonathan
J
D020022:Genetic Predisposition to Disease; D005838:Genotype; D006239:Haplotypes; D006801:Humans; D009419:Nerve Tissue Proteins / Q000235:genetics*; D020890:Neuregulin-1; D011110:Polymorphism, Genetic / Q000235:genetics; D012559:Schizophrenia / Q000235:genetics*
C094131:NRG1 protein, human; D009419:Nerve Tissue Proteins; D020890:Neuregulin-1